ACW 2.11% 7.0¢ actinogen medical limited

Ann: Xanamen Clinical Development & Investor Update, page-8

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi all,

    This was exactly the no BS ANN I was expecting, and I’m happy with this. Will discuss further on reading more, however just from the ANN there have been developments. A quick skim is not any kind of analysis. Best Wishes
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.